Use of Blockchain Can help Government To Bust Fake Drugs In India

According to two government sources, Niti Aayog is attempting to put the whole stock of pharma on blockchain with a purpose to take action against fake and false medications. The Indian government working on it and tries to complete a “proof of concept” (PoC) solution by this year-end, so can begin implementation in 2019.

Niti Aayog said that the problem of fake drugs is increasing in our country and this move can help the government and pharmaceutical companies to stop the rise of fake drugs in the country.

According to the sources, the government knows that with the consumption of fake medicines peoples are dying obviously and the idea to use blockchain technology seems the best solution to reduce this.

The fake drug industry growth rate is 20-25% every year and it worths Rs 15,000 crore. Assocham reports estimate one in five drugs are fake (both illegal copycats of brands or plain spurious with no clinical efficacy) and The Central Drugs Standard Control Organisation(CDSCO) says 0.05% to 0.3% of drugs are fake. According to the WHO (World Health Organisation) 10.5% drugs in low and middle-income countries, including India, are substandard.

The government officials did not reveal much information but according to their words, the government is very positive towards the idea to use blockchain technology. Government and Niti Aayog analyzed that if drugs details transferred on the blockchain, then there is a hierarchy of barcodes, that helps them to scan the medicines. According to sources, the government identified a partner company that will do the technology for the government and does the PoC(proof of concept) on the blockchain.

As PoC is not yet over, so it’s very early to disclose everything. India is not only the country who experiences the counterfeiting of drugs but globally more than a million people die every year after consuming fake medicines.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Ayush export declines by 7.4% in first nine months of FY 26

    Ayush export declines by 7.4% in first nine months of FY 26

    Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

    Three State Drug Testing Laboratories Functional in Jammu Kashmir: GoI

    One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure

    One more illegal drug manufacturing factory busted in Gaya, 9th Kingpin Nabbed amid Massive Seizure

    ICMR mandates clinical trials to focus on Indian demography, lifestyle

    ICMR mandates clinical trials to focus on Indian demography, lifestyle

    India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report

    India’s Medical Devices Market Is Set To Hit $50 Billion By 2030: Rubix Report

    Muradnagar Police Bust Fake Liver-52 DS Herbal Medicine Racket: Three Arrested

    Muradnagar Police Bust Fake Liver-52 DS Herbal Medicine Racket: Three Arrested